Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients.

Johannes Uhlig Omar Al-Bourini Rodrigo Salgado Marco Francone Rozemarijn Vliegenthart Jens Bremerich Joachim LotzMatthias Gutberlet

Published in: Radiology. Cardiothoracic imaging (2020)

Gadolinium-based contrast agent administration changed according to recent regulatory decisions, with use of macrocyclic agents almost exclusively in 2018 and 2019; these agents also demonstrated a favorable acute safety profile.Supplemental material is available for this article.© RSNA, 2020.

Keyphrases

contrast enhanced
magnetic resonance
end stage renal disease
magnetic resonance imaging
ejection fraction
chronic kidney disease
newly diagnosed
liver failure
computed tomography
heart failure
left ventricular
respiratory failure
transcription factor
prognostic factors
diffusion weighted imaging
patient reported